Loading clinical trials...
Loading clinical trials...
A Phase Ib, Open-Label Trial of MOv18 IgE in Patients With Solid Tumours That Overexpress Folate Receptor Alpha
Conditions
Interventions
MOv18 IgE
Locations
7
United Kingdom
Bristol Haematology and Oncology Centre
Bristol, United Kingdom
Edinburgh Cancer Research Centre
Edinburgh, United Kingdom
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Cambridge University - Addenbrooke's Hospital
London, United Kingdom
University College London Hospital
London, United Kingdom
Guy's Hospital
London, United Kingdom
Start Date
September 3, 2024
Primary Completion Date
July 1, 2026
Completion Date
March 1, 2027
Last Updated
April 6, 2026
NCT05281471
NCT06649331
NCT07029399
NCT06878248
NCT06242470
NCT06189209
Lead Sponsor
Epsilogen Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions